期刊文献+

中枢神经系统血管母细胞瘤312例临床分析及长期随访 被引量:42

Clinical data analysis and long time following up in 312 cases of central nervous system hemangioblatomas
原文传递
导出
摘要 目的探讨医学发展对本病诊治的影响.方法回顾性总结分析上海华山神经外科集团医院1974年5月至2003年12月收治的312例中枢神经系统血管母细胞瘤病人的临床资料,分3个时期比较其诊断与治疗进展情况,说明近年来医学发展对本病诊治的影响.结果本组312例中,男188例,女124例,男:女=1.52:1;年龄14~72岁,平均39岁;多发性肿瘤20例,共331个肿瘤,最常见于小脑半球或蚓部,其次是脊髓,亦可偶见于幕上;有明确家族史者19例(6.1%),确诊VHL病20例(6.4%).在前期(1974年5月至1989年7月)CT和气脑、脑室造影是主要诊断方法,术前确诊率42%;中期(1989年8月至1996年12月)和后期(1997年1月至2003年12月)CT和MRI是主要诊断手段,术前确诊率分别为58%、92%;后期还开展术前栓塞治疗.肿瘤全切率三个时期分别为83%、80.5%、97.9%,术后死亡率分别为8%、7.8%、3.1%.长期随访KPS>80分者三组分别为88.5%、92.1%、79.7%,死亡率分别为8.2%、0、3.1%.结论本病诊断主要依靠MRI,对可疑病人应做DSA检查,但早期诊断仍存在问题;手术治疗可靠有效,肿瘤全部切除可治愈本病;但实质性、家族性、多发性中枢神经系统血管母细胞瘤(HB)特别是位于脑干、脊髓时治疗仍较困难;家族性HB(VHL病),因累及脏器多,易复发,愈后较散发性差,而临床医生应加强对VHL病的重视. Objective The impact of neurosurgical progresses on patients with central nervous system hemangioblastomas (HBs) in von Hippel-Lindau (VHL) syndrome or sporadic disease was analyzed. Methods The surgical pathology database of our institution was searched to identify 312 patients with histologically verified CNS hemangioblastomas from May 1974 to Dec 2003.According to three periods, a comparison was conducted focusing on the diagnosis and treatment. Results Our study sample comprised 188 male and 124 female, with mean age of 39 years old. 19 cases(6.1%) had family history and 20 cases(6.4%) were associated with VHL disease. The mean duration of symptoms were 16.2 months. These 312 patients presented with 331 hemangioblastomas (20 patients had multiple lesions).The rate of correct preoperative diagnosis was 42%, 58% and 92% in fist period (May 1974~Jul 1989), second period(Aug 1989~Dec 1996) and third period(Jan 1997~Dec 2003) respectively. The rate of gross total removal was 83%, 80.5% and 97.9% in first period, second period and third period respectively .Comparing the preoperative and postoperative nervous system function at discharge, 89%, 84.4% and 78.4% improved in the three periods respectively. 8%, 7.8%, 3.1% died after operations in the three periods respectively. The rate of KPS>80'in three periods was 88.5%, 92.1%, 79.7% when following up from 4 months to 13 years. Conclusions MRI is the most important method to the diagnosis of HBs. DSA is valuable for the suspected cases and preoperative embolization.Surgical outcomes for patients with CNS hemangioblastomas are favorable. However, management of hemangioblastomas is a more difficult and prolonged endeavor for patients with VHL syndrome or solid tumors. Neurosurgeons should pay more attentions to VHL disease.
出处 《中华神经外科杂志》 CSCD 北大核心 2005年第2期83-87,共5页 Chinese Journal of Neurosurgery
关键词 肿瘤 血管母细胞瘤 中枢神经系统 长期随访 VHL病 治疗 确诊率 结论 时期 手段 Hemangioblastoma Diagnosis Treatment VHL MRI
  • 相关文献

参考文献11

  • 1徐启武,季耀东.颅内血管母细胞瘤100例临床分析[J].中国神经精神疾病杂志,1991,17(1):20-22. 被引量:8
  • 2王忠诚,张俊廷,刘阿力,孙波.延髓血管母细胞瘤47例报告[J].中华神经外科杂志,1999,15(5):263-268. 被引量:40
  • 3杜固宏,周良辅.中枢神经系统血管母细胞瘤的诊断和治疗[J].中国临床神经科学,1998,6(3):154-156. 被引量:4
  • 4王恩敏,张南,王滨江,潘力,周良辅,陈红,戴嘉中,蔡佩武.伽玛刀治疗血管母细胞瘤临床分析[J].中华外科杂志,2003,41(7):516-519. 被引量:18
  • 5Smrcka M, Smmka V. Central nervous system hemangioblastoma: its role in von Hippel-Lindau disease. Bratisl Lek Listy, 2000, 101,503-506.
  • 6Niemela M, Maenpaa H, Salven P, et al. Interferon alpha-2a therapy in 18 hemangioblastomas. Clin Cancer Res, 2001, 7:510-516.
  • 7Matsumoto K, Kammuki S. Hemangioblastoma and von Hippie-Lindau disease. Nippon Rinsho, 1995, 53:2672-2677.
  • 8Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science ( Washington DC ) ,1993, 260:1317-1320.
  • 9Richard S, David P, Marsot-Dupuch K, et al. Central nervous system hemangioblastotms endolymphatic sac tumors and von Hippel-Lindau disease. Neumsurg Rev, 2000 Mar, 23:1-22, discussion 23-24.
  • 10Glasker S, Bender BU, Apel TW, et al. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry, 1999,67:758-762.

二级参考文献22

  • 1LabrosseJJ 召贝贝 译.嵌入式实时操作系统uC/OS_Ⅱ[M].北京:北京航空航天大学出版社,2003..
  • 2将苟平.嵌入式可配置实时操作系统eCos开发与应用[M].北京:机械工业出版社,2004..
  • 3郑宗汉.实时系统软件基础[M].北京:清华大学出版社,2002..
  • 4Neumann HP,Eggert HR, Weigel K, et al. Hemangioblastomas of the central nervous system: a 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg, 1989, 70:24-30.
  • 5史玉泉.脑血管性肿瘤.见:史玉泉,主编.实用神经病学.第2版.上海:上海科技出版社,1994.557-564.Shi YQ. Hemangiomas of the brain. In: Shi YQ, ed. Practical neurology. 2nd ed. Shanghai: Shanghai Science & Technology Press, 1994.557-564.
  • 6Smalley SR, Schomberg PJ, Earle JD, et al. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys, 1990,18:1165-1171.
  • 7Chandler HC Jr, Friedman WA. Radiosurgical treatment of a hemangioblastoma: case report. Neurosurgery, 1994,34: 353-355.
  • 8Niemela M, Lim YJ, Soderman M, et al. Gamma knife radiosurgery in 11 hemangioblastomas. J Neurosurg, 1996,85: 591-596.
  • 9Page KA, Wayson K, Steinberg GK, et al. Stereotacxic radiosurgical ablation: an alternative treatment for recurrent and multifocal hemangioblastomas: a report of four cases. Surg Neurol, 1993, 40: 424-428.
  • 10Chang SD, Meisel JA, Hancock SL, et al. Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery. Neurosurgery, 1998, 43:28-34.

共引文献60

同被引文献258

引证文献42

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部